Nektar Therapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 15.97 M | $20.76 M | 100.00% | 7.63% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 15.92 M | $20.70 M | -10.92% | 7.61% |
| VANGUARD GROUP INC | 11/13/2024 | 13.12 M | $17.06 M | 1.18% | 6.27% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 9.40 M | $12.22 M | 24.85% | 4.49% |
| SAMLYN CAPITAL, LLC | 11/14/2024 | 9.20 M | $11.96 M | -2.73% | 4.40% |
| CITADEL ADVISORS LLC | 11/14/2024 | 6.95 M | $9.04 M | 0.00% | 3.32% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 5.91 M | $7.69 M | -1.79% | 2.83% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 5.65 M | $7.35 M | 15.77% | 2.70% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 5.06 M | $6.58 M | 8.63% | 2.42% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 4.11 M | $5.34 M | 0.00% | 1.96% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 4.00 M | $5.20 M | 0.00% | 1.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.96 M | $5.15 M | -3.63% | 1.89% |
| STATE STREET CORP | 11/14/2024 | 3.35 M | $4.35 M | 11.90% | 1.60% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 3.33 M | $4.33 M | 0.42% | 1.59% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 2.79 M | $3.63 M | -2.78% | 1.33% |
| MONACO ASSET MANAGEMENT SAM | 11/07/2024 | 2.00 M | $2.60 M | -7.81% | 0.95% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.78 M | $2.32 M | 0.90% | 0.85% |
| WOODLINE PARTNERS LP | 11/14/2024 | 1.73 M | $2.25 M | 178.00% | 0.83% |
| SHAY CAPITAL LLC | 11/14/2024 | 1.60 M | $2.07 M | -13.32% | 0.76% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 1.50 M | $1.95 M | -18.28% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.45 M | $1.89 M | -2.26% | 0.69% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 1.36 M | $1.77 M | -24.65% | 0.65% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.36 M | $1.77 M | 100.00% | 0.65% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 1.31 M | $1.71 M | 0.00% | 0.63% |
| UBS OCONNOR LLC | 11/14/2024 | 1.15 M | $1.50 M | 10.24% | 0.55% |
| ACUITAS INVESTMENTS, LLC | 11/07/2024 | 1.10 M | $1.43 M | 24.61% | 0.52% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 1.00 M | $1.30 M | 19.62% | 0.48% |
| ALMITAS CAPITAL LLC | 11/14/2024 | 920,225 | $1.20 M | 0.00% | 0.44% |
| JPMORGAN CHASE & CO | 12/26/2024 | 913,300 | $1.19 M | 197.26% | 0.44% |
| CM MANAGEMENT, LLC | 11/12/2024 | 750,000 | $975,000 | 0.00% | 0.36% |
| MORGAN STANLEY | 11/14/2024 | 746,114 | $969,949 | -49.33% | 0.36% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 650,841 | $846,093 | 5.61% | 0.31% |
| INVESCO LTD. | 11/12/2024 | 646,808 | $840,850 | 0.40% | 0.31% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 504,224 | $654,496 | -2.28% | 0.24% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 501,590 | $626,987 | 100.00% | 0.24% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 473,090 | $615,017 | 100.00% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 410,316 | $533,411 | -25.60% | 0.20% |
| FMR LLC | 11/13/2024 | 386,656 | $502,653 | 403.24% | 0.18% |
| BARCLAYS PLC | 11/19/2024 | 358,294 | $466,000 | 96.11% | 0.17% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 348,968 | $453,658 | 0.00% | 0.17% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 326,716 | $424,731 | -6.63% | 0.16% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 300,352 | $390,458 | 13.74% | 0.14% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 281,602 | $366,083 | -3.54% | 0.13% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 280,366 | $364,000 | 100.00% | 0.13% |
| MACQUARIE GROUP LTD | 11/14/2024 | 256,385 | $333,000 | 0.00% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 218,263 | $283,742 | 19.90% | 0.10% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 214,245 | $279,000 | -76.99% | 0.10% |
| RHUMBLINE ADVISERS | 11/12/2024 | 183,140 | $238,078 | -1.07% | 0.09% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 182,037 | $237,000 | 0.00% | 0.09% |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 11/15/2024 | 159,064 | $206,783 | -0.62% | 0.08% |
Nektar Therapeuticsinstitutional Ownership - FAQ's
During the previous two years, 257 institutional investors and hedge funds held shares of Nektar Therapeutics. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 15.97 M
Deep Track Capital, LP: 15.92 M
VANGUARD GROUP INC: 13.12 M
EVENTIDE ASSET MANAGEMENT, LLC: 9.4 M
SAMLYN CAPITAL, LLC: 9.2 M
CITADEL ADVISORS LLC: 6.95 M
67.25% of Nektar Therapeutics stock is owned by institutional investors.
Institutional investors have bought a total of 201.70 M shares in the last 24 months. This purchase volume represents approximately $197.66 M in transactions.